Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07613853 · ClinicalTrials.gov registry record · NA

The Return of Cardiovascular Information Trial (RECITE)

A NA study, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
NA
Development phase
1,500
Enrollment target

NCT07613853 is a NA study that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 1,500 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07613853, a NA study, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
NA
Development phase
1,500 participants
Enrollment target

Study Summary

The goal of this behavioral interventional trial is to determine how best to communicate personalized cardiovascular risk information and support behavior change among participants enrolled in the Dallas Heart Study (DHS) cohort. The main questions it aims to answer are: * What are the effects of presenting health information in a coarse vs. granular manner? (This question will be measured by randomizing participants to two groups: one group will get a cover letter with their health information communicated in a more detailed manner, while another group will receive a cover letter which presents their health information in a coarse manner. Two letters will be sent containing the same information regarding their results. 4 months after the second letter, participants will be asked about changes made for their health after receiving the letter) * How curious are people about bettering their health after being presented their health information? (This question will be measured by placing QR codes linking educational health videos on each cover letter. Each letter will be sent twice with exactly the same health information but with new QR (Quick Response) codes. QR code use will be tracked by the study staff) Researchers will assess whether participants who received different style letters had different responses to their health behaviors and medication afterward and will measure this with a follow-up phone call. Researchers will also assess the use of QR codes showing health-related videos (about physical activity, heart-healthy diet, diabetes medication, statin medication) by sending out two different letters with the same health information and format, but with different QR code-linked videos. Participants will: * Receive two letters in the mail, 4 weeks apart, containing their results from the Dallas Heart Study's 4th visit. The cover letter for this report will be randomized and will contain coarse vs. granular presentations of the participant's heart health ri

Interventions

  • BEHAVIORAL Coarse health result information presentation
  • BEHAVIORAL Granular health risk information presentation

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2026-04-22
Est. Completion 2028-08
Phase NA

What the Registry Record Tells You About NCT07613853

The ClinicalTrials.gov registry entry for NCT07613853 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Coarse health result information presentation is the first listed.

NCT07613853 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07613853 about?

NCT07613853 is a clinical study titled "The Return of Cardiovascular Information Trial (RECITE)". The goal of this behavioral interventional trial is to determine how best to communicate personalized cardiovascular risk information and support behavior change among participants enrolled in the Dallas Heart Study (DHS) cohort. The main questions it aims to answer are: * What are the effects of p...

What is the current status of trial NCT07613853?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,500 participants. The study started on 2026-04-22. Estimated completion is 2028-08.

What interventions are being tested in trial NCT07613853?

The interventions under investigation include: Coarse health result information presentation (BEHAVIORAL), Granular health risk information presentation (BEHAVIORAL).

Who is sponsoring clinical trial NCT07613853?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.